Granules India signs MOU with PharmaMatch B.V

Granules India Ltd has announced that PharmaMatch B.V., and the Company have announced the signing of a Memorandum of Understanding (MOU) to develop, manufacture and market formulations in the European Market jointly.

This arrangement will kick-off with the transfer of existing marketing authorizations by PharmaMatch to the Company for products like Paracetamol where the Company is basic and has the necessary skill, sets to deliver the same. This will use the upcoming finished dosage facility of the Company which is expected to be commissioned and fully operational by May 2007.

Mr. C Krishna Prasad, Managing Director of the Company, said, "PharmaMatch is a renowned finished dosage player in European Union and we expect this relationship to catapult Granules strongly into the European Market. We are expecting this development to speeden up the approval process for the finished dosage facility in the European Union".

Source : Equity Bulls

Keywords